Skip to main content
SpringerLink
Log in

Empfehlungen der Deutschen Gesellschaft für Rheumatologie zur Therapie des Raynaud-Syndroms und akraler Ulzerationen

  • BEITRAG ZUM SCHWERPUNKTTHEMA
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Neirotti M, Longo F, Molaschi M, Macchione C, Pernigotti L (1987) Functional vascular disorders: treatment with pentoxifylline. Angiology 38:575–580

    Google Scholar 

  2. Thompson AE, Shea B, Welch V, Fenlon D, Pope JE (2001) Calcium-channel blockers for Raynaud’s phenomenon in systemic sclerosis. Arthritis Rheum 44:1841–1847

    Google Scholar 

  3. Tosi S, Marchesoni A, Messina K, Bellintani C, Sironi G, Faravelli C (1987) Treatment of Raynaud’s phenomenon with captopril. Drugs Exp Clin Res 13:37–42

    Google Scholar 

  4. Coleiro B, Marshall SE, Denton CP, Howell K, Blann A, Welsh KI, Black CM (2001) Treatment of Raynaud’s phenomenon with the selective serotonin reuptake inhibitor fluoxetine. Rheumatology 40:1038–1043

    Google Scholar 

  5. Denton CP, Howell K, Stratton RJ, Black CM (2000) Long-term low molecular weight heparin therapy for severe Raynaud’s phenomenon: a pilot study. Clin Exp Rheumatol 18:499–502

    Google Scholar 

  6. Pope J, Fenlon D, Thompson A, Shea B, Furst D, Wells G, Silman A (2000) Iloprost and cisaprost for Raynaud’s phenomenon in progressive systemic sclerosis. Chochrane Database Syst Rev:CD000953

    Google Scholar 

  7. Rosenkranz S, Diet F, Karasch T, Weihrauch J, Wassermann K, Erdmann E (2003) Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the raynaud phenomenon. Ann Intern Med 139:871–873

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charité, Schumannstraße 20/21, 10117, Berlin, Germany

    G. Riemekasten

Authors
  1. G. Riemekasten
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Riemekasten.

Additional information

und die Kommission Pharmakotherapie der DGRh

Rights and permissions

Reprints and permissions

About this article

Cite this article

Riemekasten, G. Empfehlungen der Deutschen Gesellschaft für Rheumatologie zur Therapie des Raynaud-Syndroms und akraler Ulzerationen. Z. Rheumatol. 64, 90–92 (2005). https://doi.org/10.1007/s00393-005-0692-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-005-0692-x

Search

Navigation